Refractory, symptomatic, recurrent Ovarian Cancer With Malignant Ascites

Also known as: Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB15558	Imalumab	1 / 2	Terminated	1